Extra-articular manifestations and complications of rheumatoid arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 21, Issue 5, 2007, Pages 907-927

  Young, Adam ^a,b   Koduri, Gouri ^a  

^a WEST HERTFORDSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

extra articular rheumatoid disease; RA comorbidity; RA complications; rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; STEROID;

ANEMIA; BACTERIAL ARTHRITIS; CARPAL TUNNEL SYNDROME; CERVICAL SPINE DISLOCATION; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FELTY SYNDROME; FRAGILITY FRACTURE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; LEG ULCER; LUNG DISEASE; LUNG FIBROSIS; MORTALITY; NONARTICULAR RHEUMATISM; NONHODGKIN LYMPHOMA; NORMOCHROMIC NORMOCYTIC ANEMIA; OSTEOPOROSIS; PATHOGENESIS; PERICARDIAL EFFUSION; PHYSICAL DISABILITY; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; RISK FACTOR; SEX DIFFERENCE; SJOEGREN SYNDROME; SMOKING; SURGICAL DRAINAGE; VASCULITIS;

ARTHRITIS, RHEUMATOID; COMORBIDITY; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 34548509677     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2007.05.007     Document Type: Review

References (53)

1. Gordon D.A., Stein J.L., and Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. The American Journal of Medicine 54 (1973) 445-452
2. Turesson C., Jacobsson L., and Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 38 (1999) 668-674
3. Young A., Dixey J., Cox N., et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford) 39 (2000 Jun) 603-611
4. Turesson C., Jacobsson L., Bergström U., et al. Predictors of extra-articular manifestations in rheumatoid arthritis. Scandinavian Journal of Rheumatology 29 (2000) 358-364
5. Fleming A., Dodman S., and Corbett M. Extra-articular features in early rheumatoid arthritis. British Medical Journal 1 (1976) 1241-1243
6. Wilson A., Yu H.T., Goodnough L.T., and Nissenson A.R. Prevalence and outcomes of anaemia in rheumatoid arthritis: a systematic review of the literature. The American Journal of Medicine 116 (2004) 50S-57S
7. Symmons D. Lymphoma and rheumatoid arthritis-again. Rheumatology 46 1 (2007) 1-2
8. Van Staa T.P., Guesens P., Bijlsma J.W.J., et al. Clinical assessment of the long term risk of fracture inpatients with RA. Arthritis and Rheumatism 54 (2006) 3104-3112
9. Myllykangas-Luosujarvi R., Aho K., and Isomaki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. The Journal of rheumatology 22 12 (1995) 2200-2202
10. Young A., Koduri G., Batley M., et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 45 (2006) 350-357
11. Kearney P.M., Baigent C., Godwin, et al. Do selective cyto-oxygenase inhibitors and traditional non steroidal anti inflammatory drugs increase risk of athero thrombosis? Meta-analysis of randomised trials. British Journal of Rheumatology 332 (2006) 1302-1305
12. Bonfiglio T., and Atwater C. Heart disease in patients with seropositive RA. Archives of internal medicine 124 (1969) 714-719
13. Manzi S., and Wasko M.C.M. Inflammation-mediated rheumatic diseases and atherosclerosis. Annals of the Rheumatic Diseases 59 (2000) 321-325
14. Ridker P., Cushman M., Stampfer M., et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. The New England Journal of Medicine (1997) 973-979
15. McMahon M.J., Swinson D.R., Shettar S., et al. Bronchiectasis and rheumatoid arthritis: a clinical study. Annals of the Rheumatic Diseases 52 (1993) 776-779
16. Turesson C., O'Fallon W.M., Crowson C.S., et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. The Journal of rheumatology 29 (2002) 62-67
17. Gabriel S.E., Crowson C.S., Kremers H.M., et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis and Rheumatism 48 (2003) 54-58
18. Voskuyl A.E., Zwinderman A.H., Westedt M.L., et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Annals of the Rheumatic Diseases 55 (1996) 190-192
19. Conn D.L., McDuffie F.C., and Dyke P.J. Immunpathological studies of sural nerves in RA. Arthritis and Rheumatism 15 (1972) 135-143
20. Turesson C, McClelland RL, Christianson TJH et al. Incidence and predictors of severe extraarticular disease manifestations in an early RA inception cohort [in press].
21. Turesson C., McClelland R.L., Christianson T.J., and Matteson E.L. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis and Rheumatism 50 (2004) 3729-3731
22. Watts R.A., Mooney J., Lane S.E., and Scott D.G. Rheumatoid vasculitis: becoming extinct?. Rheumatology (Oxford) 43 (2004) 920-923
23. Ward M.M. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis and Rheumatism 50 (2004) 1122-1131
24. Drosos A.A., Lanchbury J.S., and Panayi G.S. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiology and serology study. Arthritis and Rheumatism 35 (1992) 745-748
25. Carmona L., and Gonzalez-Alvaro I. Rheumatoid arthritis in Spain:occurrence of extra-articular manifestations and estimates of disease severity. Annals of the Rheumatic Diseases 62 (2003) 897-900
26. Cimmino M.A. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatology International 19 (2000) 213-217
27. Salvarani C., Macchioni P., Mantovani W., et al. Extraarticular manifestations of RA and HLA antigens in northern Italy. Rheumatology 19 (1992) 242-246
28. Benazet J.F., Reviron D., Mercier P., et al. HLA-DRB1 alleles associated with RA in southern France. Absence of extraarticular disease despite expression of the shared epitope. Rheumatology 4 (1995) 607-610
29. Perdringer A., Chales G., Semana G., et al. Role of HLA-DR-DR & DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factors in RA. Rheumatology 7 (1997) 1272-1276
30. Agrawal S., Dabadghos A., Nach S., and Misra R. Compound heterozygosity of HLA-DR4 and DR1 antigens in Asian Indians increases the risk of extra-articular features in RA. British Journal of Rheumatology 34 (1995) 41-44
31. Rycke D., Peene I., Hoffman I.E., et al. Rheumatoid Factor and anti CCP ab in RA: diagnostic value, associations with radiological progression rate and extraarticular manifestations. Annals of the Rheumatic Diseases 12 (2004) 1587-1593
32. Turesson C., and Jacobsson L.T. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scandinavian Journal of Rheumatology 33 (2004) 65-72
33. Turesson C., Schaid D.J., Weyand C.M., et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations of RA. Arthritis Research & Therapy (2005) R1386-R1393
34. Ioannidis J.P.A., Tarassi K., Papadopoulos I.A., et al. Shared epitope and RA: disease associations in Greece and meta-analysis of Mediterranean European populations. Seminars in Arthritis and Rheumatism 31 (2002) 361-370
35. Young A., Corbett M., Jaqueremada D., et al. HLA Antigen Associations with Radiological Changes in the Hands, Feet and Cervical Spines in Early Rheumatoid Arthritis. Disease Markers 4 (1986) 133-137
36. Winfield J., Young A., Williams P., and Corbett M. A Prospective Study of the Radiological Changes of Hands, Feet & Cervical Spine in Adult Rheumatoid Disease. Annals of the Rheumatic Diseases 42 (1983) 613-618
37. Jonsson T., Arinbjarnarson S., Thorsteinsson J., et al. Scandinavian Journal of Rheumatology 24 (1995) 372-375
38. Turesson C., Jacobsson L.T.H., Sturfelt G., et al. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Annals of the Rheumatic Diseases 65 (2006) 1533
39. Rajasekaran B.A., Shovlin D., Lord P., and Kelly C.A. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 40 (2001) 1022-1025
40. Asmussen K.H., and Bowman S.J. Outcome measures in Sjogrens syndrome. Rheumatology 40 (2001) 1085-1088
41. Bansback N.J., Young A., Brennan A., and Dixey J. A prognostic model for functional outcome in early rheumatoid arthritis. The Journal of Rheumatology 33 (2006) 8
42. Young A., Wilkinson P., James D., et al. Socio-economic factors in the presentation and outcome of early rheumatoid arthritis. Lessons for the health service?. Annals of the Rheumatic Diseases 59 (2000) 794-799
43. Kobelt G., Jonsson L., Lindgren P., et al. Modelling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of RA. Arthritis and Rheumatism 46 (2002) 2310-2319
44. Young A., Dixey J., Kulininska E., et al. Which patients with early RA stop working? Results from a 5yr inception cohort of 732 patients. Annals of the Rheumatic Diseases 61 (2002) 335-340
45. James D., Young A., Kulinskaya E., et al. Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1029 patients followed for 5 years. Rheumatology (Oxford) 43 (2004) 369-376
46. Dixey J., Young A., Solymossy C., et al. Is it possible to predict radiological damage in early RA? A report on occurrence, progression and prognostic factors for radiological erosions over first 3 years in 860 patients from early RA study (ERAS). The Journal of Rheumatology 31 supplement 69 (2004) 48-54
47. Kelly C.A. Rheumatoid arthritis, classic lung disease. Bailliere's Clinical Rhematology 7 (1993) 1-16
48. Turesson C., O'Fallon W.M., Crowson C.S., et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases 62 (2003) 722-727
49. Kelly C., and Hamilton J. What kills patients with rheumatoid arthritis?. Rheumatology (Oxford) 46 (2007) 183-184
50. Voskuyl. A.E. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) 45 supplement 4 (2006) iv4-iv7
51. Turesson C., McClelland R.L., Christianson T.J.H., et al. Severe extra-articular diseasemanifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoidarthritis. Annals of the Rheumatic Diseases 66 (2007) 70-75
52. Solomon D.H., and Goodson N.J. The Cardiovascular system in Rheumatic Disease: the newest "extra-articular" manifestation?. The Journal of Rheumatology 32 (2005) 1415-1417 Editorial
53. Alarcon G.S., Kremer J.M., Macaluso M., et al. Risk factors for methotrexate lung injury in patients with RA. Methotrexate Lung Study Group. Annals of internal medicine 127 (1997) 356-364